HTB homepage • Conference reports • Articles by subject • Subscribe December 2012 Contents Editorial Volume 13 Number 11/12 November/December 2012 Conference reports 11th International Congress on Drug Therapy in HIV, 11-15 November 2012, Glasgow Issues that divide expert opinion: when to start, HIV and ageing and the impact of HIV on life expectancy Dolutegravir: integrase resistance and the impact of the background regimen Updated results on Quad: 96 week data from phase 3 studies HIV/HCV coinfection: early glimpses of an interferon-free future and EuroSIDA incidence data Resistance in infants and children receiving ART in South Africa 63rd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), 9-13 November 2012, Boston Cure rates with pipeline HCV drugs: reports from AASLD 3rd International Workshop on HIV and ageing, 5-6 November 2012, Baltimore BHIVA Autumn Conference, 6-7 October 2012, London Antiretrovirals Darunavir 800 mg tablet approved in the US Treatment access FDA approval of generic ARVs d4T – time to move on Global Fund provides ART for 4.2 million people: 2012 update $84 million grant to Zimbabwe to reach universal access in 2012 Mark Dybul to be the next executive director of the Global Fund US NIH to enforce open access to clincal trial results Pregnancy The challenge of adherence during pregnancy and after Paediatric care ART and adverse birth outcomes in Botswana Guidelines UK Standards for HIV Care launched by BHIVA (2012) Side effects Low incidence of liver-related deaths in HIV positive people without HBV and/or HCV co-infection Rapid drop in mitochondria in fat biopsies within four weeks of d4T use High dose multivitamin use in advanced HIV has no benefit to CD4 and viral load and may cause liver toxicity HIV prevention and transmission Quantifying HIV-1 exposure to illuminate resistance to infection Immune activation, inflammation and HIV acquisition risk Cure-related research Hopes raised by HDAC inhibitor, but uncertainties remain Post-treatment control of HIV replication and prospects for a functional cure Book and film reviews Bad Pharma: How drug companies mislead doctors and harm patients: by Ben Goldacre Other news HIV in the United Kingdom: 2012 report Hepatitis C in the UK: 2012 report New Frontiers: Inaugural meeting of the British Society for Nanomedicine Anti-homosexuality laws back in African parliaments PDFs Volume 13 Number 11/12 November/December 2012 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
